CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
University of California, San Francisco |
Dr. Shuvo Roy |
Quest – Discovery Stage Research Projects |
Silicon Nanopore Membrane encapsulated enriched-Beta Clusters for Type 1 Diabetes treatment |
$1,113,000 |
University of California, Los Angeles |
Dr. Scott G Kitchen |
Quest – Discovery Stage Research Projects |
Engineering Lifelong Cellular Immunity to HIV |
$1,701,178 |
University of California, San Diego |
Dr. Tannishtha Reya |
Quest – Discovery Stage Research Projects |
Targeting Cancer Stem Cells in Hematologic Malignancies |
$1,960,560 |
University of California, Los Angeles |
Dr. Thomas Carmichael M.D., Ph.D. |
Quest – Discovery Stage Research Projects |
iPS Glial Therapy for White Matter Stroke and Vascular Dementia |
$2,086,130 |
University of California, Los Angeles |
Dr. April Pyle Ph.D. |
Quest – Discovery Stage Research Projects |
Identification and Generation of Long Term Repopulating Human Muscle Stem Cells from Human Pluripotent Stem Cells |
$2,148,519 |
Stanford University |
Dr. Kyle M Loh |
Quest – Discovery Stage Research Projects |
Towards hepatocyte cell replacement therapy: developing a renewable source of human hepatocytes from pluripotent stem cells |
$1,968,456 |
University of California, San Diego |
Mark H Tuszynski |
Quest – Discovery Stage Research Projects |
Neural Stem Cell Relays for Severe Spinal Cord Injury |
$1,638,900 |
Stanford University |
Dr. Helen M Blau |
Quest – Discovery Stage Research Projects |
Stimulating endogenous muscle stem cells to counter muscle atrophy |
$2,198,687 |
ViaCyte, Inc. |
Dr. Alan D. Agulnick |
Quest – Discovery Stage Research Projects |
Preclinical development of an immune evasive islet cell replacement therapy for type 1 diabetes |
$1,470,987 |
University of California, San Diego |
Dr Yang Xu |
Quest – Discovery Stage Research Projects |
Development of immune invisible beta cells as a cell therapy for type 1 diabetes through genetic modification of hESCs |
$1,924,791 |
Neurona Therapeutics |
Dr. Cory R Nicholas |
Quest – Discovery Stage Research Projects |
Development of a Cellular Therapeutic for Treatment of Epilepsy |
$1,616,536 |
City of Hope, Beckman Research Institute |
Dr. Saswati Chatterjee |
Quest – Discovery Stage Research Projects |
Genome Editing of Sinusoidal Endothelial Stem Cells for Permanent Correction of Hemophilia A |
$2,182,193 |
University of California, Irvine |
Dr. Brian J. Cummings |
Quest – Discovery Stage Research Projects |
Identification and characterization of the optimal human neural stem cell line (hNSC) for the treatment of traumatic brain injury (TBI) 2.0. |
$1,671,213 |
University of California, Los Angeles |
Dr. Vaithilingaraja Arumugaswami PhD |
Quest – Discovery Stage Research Projects |
Immunization strategies to prevent Zika viral congenital eye and brain disease |
$2,128,867 |
Rumi Scientific CA |
Ali H. Brivanlou |
Quest – Discovery Stage Research Projects |
Discovery of therapeutics for Huntington’s Disease |
$1,399,800 |
University of California, Los Angeles |
UCLA Gay M Crooks |
Quest – Discovery Stage Research Projects |
Platform Technology for Pluripotent Stem Cell-Derived T cell Immunotherapy |
$965,636 |
X-Therma Inc. |
Dr. Xiaoxi Wei |
Quest – Discovery Stage Research Projects |
Non-Toxic, Highly-Effective Bioinspired Cryoprotectants for On-Demand Stem Cell Therapies |
$887,883 |
University of California, Los Angeles |
Dr. Caroline Y. Kuo |
Quest – Discovery Stage Research Projects |
Targeted Gene Editing in the Treatment of X-Linked Hyper-IgM Syndrome |
$1,512,333 |
University of California, Davis |
Dr. Deborah K Lieu |
Quest – Discovery Stage Research Projects |
Microenvironment for hiPSC-derived pacemaking cardiomyocytes |
$2,042,438 |
Stanford University |
Dr. Mark Mercola |
Quest – Discovery Stage Research Projects |
Multipotent Cardiovascular Progenitor Regeneration of the Myocardium after MI |
$1,809,234 |
University of California, San Diego |
Professor Yuan Chen |
Quest – Discovery Stage Research Projects |
A Novel Approach to Eradicate Cancer Stem Cells |
$279,977 |
City of Hope, Beckman Research Institute |
Professor Yuan Chen |
Quest – Discovery Stage Research Projects |
A Novel Approach to Eradicate Cancer Stem Cells |
$1,539,935 |
University of California, Berkeley |
Kevin E. Healy |
Quest – Discovery Stage Research Projects |
Human Cardiac Chip for Assessment of Proarrhythmic Risk |
$899,581 |
University of California, San Francisco |
Dr. Holger F Willenbring |
Quest – Discovery Stage Research Projects |
Preclinical development of AAV vector-mediated in vivo hepatic reprogramming of myofibroblasts as a therapy for liver fibrosis |
$1,638,389 |
Scaled Biolabs Inc. |
Dr Justin Cooper-White |
Quest – Discovery Stage Research Projects |
A tool for rapid development of clinical-grade protocols for dopaminergic neuronal differentiation of Parkinson’s Disease patient-derived iPSCs |
$657,528 |
City of Hope, Beckman Research Institute |
Markus Müschen |
Quest – Discovery Stage Research Projects |
Lgr5-mediated self-renewal in B cell selection and leukemia-initiation |
$2,183,223 |
University of California, San Diego |
Professor Alysson R Muotri |
Quest – Discovery Stage Research Projects |
A treatment for Zika virus infection and neuroprotection efficacy |
$1,924,524 |
Stanford University |
Dr. Matthew H Porteus |
Quest – Discovery Stage Research Projects |
Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells |
$1,968,456 |
University of California, San Francisco |
Dr. Julie B Sneddon |
Quest – Discovery Stage Research Projects |
Designing a cellular niche for transplantation of human embryonic stem cell-derived beta cells |
$2,006,076 |
University of California, Los Angeles |
Dr. John P Chute |
Quest – Discovery Stage Research Projects |
Protein tyrosine phosphatase – sigma inhibitors for hematopoietic regeneration |
$2,115,735 |
University of California, San Diego |
Dan S Kaufman |
Quest – Discovery Stage Research Projects |
Targeted off-the-shelf immunotherapy to treat refractory cancers |
$1,936,936 |
Parkinson’s Institute |
Dr. Birgitt Schuele |
Quest – Discovery Stage Research Projects |
CRISPR/dCas9 mutant targeting SNCA promoter for downregulation of alpha-synuclein expression as a novel therapeutic approach for Parkinson’s disease |
$1,288,415 |
Gladstone Institutes, J. David |
Dr. Deepak Srivastava |
Quest – Discovery Stage Research Projects |
Direct Cardiac Reprogramming for Regenerative Medicine |
$2,392,157 |
University of California, Irvine |
Leslie M Thompson |
Quest – Discovery Stage Research Projects |
hNSC-mediated delivery of ApiCCT1 as a candidate therapeutic for Huntington’s disease |
$1,650,263 |
Stanford University |
Dr. Roel Nusse |
Quest – Discovery Stage Research Projects |
Preclinical development of human hepatocyte progenitor cells for cell therapy |
$1,651,211 |
University of California, San Francisco |
Dr. Tejal Ashwin Desai |
Quest – Discovery Stage Research Projects |
Thin Film Encapsulation Devices for Human Stem Cell derived Insulin Producing Cells |
$1,092,063 |
Stanford University |
Dr. Rosa Bacchetta |
Quest – Discovery Stage Research Projects |
GENE EDITING FOR FOXP3 IN HUMAN HSC |
$984,228 |
California Institute of Technology |
Dr. David Baltimore PhD |
Quest – Discovery Stage Research Projects |
Immunotherapy for HIV infection using engineered hematopoietic stem/progenitor cells |
$1,569,193 |
Gladstone Institutes, J. David |
Dr. Deepak Srivastava |
Quest – Discovery Stage Research Projects |
Use of Human iPSC-derived Endothelial Cells for Calcific Aortic Valve Disease Therapeutics |
$2,400,048 |
Scripps Research Institute |
Dr. Jeanne F Loring |
Quest – Discovery Stage Research Projects |
Autologous cell therapy for Parkinson’s disease using iPSC-derived DA neurons |
$2,299,786 |
University of California, Davis |
Dr. David J Segal PhD |
Quest – Discovery Stage Research Projects |
MSC delivery of an artificial transcription factor to the brain as a treatment for Angelman Syndrome |
$1,055,319 |
University of California, Berkeley |
Dr. David V. Schaffer |
Quest – Discovery Stage Research Projects |
Scalable, Defined Production of Oligodendrocyte Precursor Cells to Treat Neural Disease and Injury |
$1,627,099 |
Stanford University |
Professor Hiromitsu Nakauchi |
Quest – Discovery Stage Research Projects |
Novel Rejuvenated T Cell Immunotherapy for Lung Cancer |
$1,968,456 |
University of California, Los Angeles |
Dr. April Pyle Ph.D. |
Quest – Discovery Stage Research Projects |
CRISPR/Cas9 nanoparticle enabled therapy for Duchenne Muscular Dystrophy in muscle stem cells |
$2,150,400 |
University of California, San Diego |
Karl Karl J. Wahlin |
Inception – Discovery Stage Research Projects |
An IPSC cell based model of macular degeneration for drug discovery. |
$232,200 |
University of California, Los Angeles |
Alireza Moshaverinia |
Inception – Discovery Stage Research Projects |
Gingival mesenchymal stem cells as a novel treatment modality for periodontal tissue regeneration |
$194,483 |
Zenobia Therapeutics |
Vicki Nienaber |
Inception – Discovery Stage Research Projects |
A new phenotypic screening platform that identifies biologically-relevant targets and lead compounds for the treatment of Parkinson’s disease |
$112,500 |
Cedars-Sinai Medical Center |
Dmitriy Sheyn |
Inception – Discovery Stage Research Projects |
IVD rejuvenation using iPSC-derived notochordal cells |
$241,992 |
Loma Linda University |
Dr. David J Baylink |
Inception – Discovery Stage Research Projects |
Bone Marrow Targeting of Hematopoietic Stem Cells Engineered to Overexpress 25-OH-VD3 1-α-hydroxylase for Acute Myeloid Leukemia Therapy |
$178,967 |
Palo Alto Veterans Institute for Research |
Dr. Ngan F Huang |
Inception – Discovery Stage Research Projects |
iPSC-Derived Smooth Muscle Progenitors for Treatment of Abdominal Aortic Aneurysm |
$172,621 |